Effect of p2 receptor on the intracellular calcium increase by cancer cells in human umbilical vein endothelial cells

April 12th, 2008 by admin

Abstract  One of the essential functions of tube endothelial cells is as a obstruction between murder and tube tissue. This led us
to put that cancer cells change endothelial cells during metastasis. In the inform study, we investigated the influence
of manlike fibrosarcoma cells (HT-1080) on manlike umbilical varicosity endothelial cells (HUVEC), specially intracellular calcium
ion levels ([Ca2+]i), which are famous to be an essential intracellular communication transduction factor. HUVEC were aerated with a fluorescent marker,
and the fluorescence grade of [Ca2+]i was then rhythmic by form oppositeness atomlike imaging. Extracellular adenosine triphosphate (ATP) promulgation was measured
using the chemiluminescence of luciferin–luciferase and a photon reckoning imagery system. HT-1080 (5 × 104 cells per dish) was institute to process [Ca2+]i in HUVEC. This [Ca2+]i uprise was significantly low by U-73122 (phospholipase C inhibitor, 1 μM) and thapsigargin (calcium viscus inhibitor, 1 μM).
Interestingly, the [Ca2+]i uprise in HUVEC was also significantly low by pyridoxalphosphare-6-azophenyl-2′, 4′-disulfonic acid, a P2Y organ antagonist
(100 μM) and apyrase, a nucleotidase inhibitor (2 U/ml). In addition, we observed nucleotide promulgation from HT-1080. These results
declare that [Ca2+]i in HUVEC was accumulated finished the phospholipase C-IP3 path via nucleotide promulgation from cancer cells. We previously reportable that extracellular nucleotide accumulated [Ca2+]i and enhanced macromolecular porousness via the P2Y receptor. In growth metastasis, cancer cells haw utilise these regulatory
mechanisms in the endothelial radiophone layer.

Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00210-007-0259-2Authors
Namie Nejime, Mukogawa Women’s University Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences Nishinomiya 663-8179 JapanNaoko Tanaka, island University of Health and Welfare First Department of Pharmacology, School of Pharmaceutical Sciences Nobeoka Miyazaki 882-8508 JapanRyoko Yoshihara, Mukogawa Women’s University Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences Nishinomiya 663-8179 JapanSatomi Kagota, Mukogawa Women’s University Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences Nishinomiya 663-8179 JapanNoriko Yoshikawa, Mukogawa Women’s University Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences Nishinomiya 663-8179 JapanKazuki Nakamura, Mukogawa Women’s University Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences Nishinomiya 663-8179 JapanMasaru Kunitomo, Mukogawa Women’s University Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences Nishinomiya 663-8179 JapanMichio Hashimoto, Shimane University Faculty of Medicine Department of Environmental Physiology Izumo 693-8501 JapanKazumasa Shinozuka, Mukogawa Women’s University Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences Nishinomiya 663-8179 Japan

Journal Naunyn-Schmiedeberg’s Archives of PharmacologyOnline ISSN 1432-1912Print ISSN 0028-1298 (Source: Naunyn-Schmiedeberg’s Archives of Pharmacology)

Tags: , , , , , , , , ,

Posted in Cancer |

Related posts

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.